▼ Summary
– Robert F. Kennedy Jr. is urging the FDA to lift restrictions on over a dozen injectable peptide treatments that were banned for safety risks.
– These unproven peptides have become popular online among wellness influencers who make unsupported claims about their benefits.
– Kennedy promoted these peptides on Joe Rogan’s podcast and vowed to end what he calls the FDA’s “war” on them.
– The FDA reclassified these peptides in 2023, banning compounding pharmacies from making them for human use due to significant safety concerns.
– Despite the ban, a black and gray market for these peptides persists, with some of Kennedy’s allies involved in selling them.
The push to deregulate certain injectable peptide treatments is gaining a prominent voice, one that stands in stark contrast to established medical and regulatory consensus. Health Secretary Robert F. Kennedy Jr., a figure known for his skepticism toward conventional vaccines, is now urging the Food and Drug Administration to reverse its restrictions on more than a dozen of these substances. The FDA imposed those limits specifically because the treatments lack proven efficacy and present significant safety risks, a stance supported by scientific review rather than the anecdotal claims driving their popularity.
Kennedy has openly declared himself an enthusiast of these compounds. Peptides are fundamentally chains of amino acids that serve various cellular functions. Some, like insulin or certain weight-loss drugs, are well-established, FDA-approved medications. The current controversy, however, revolves around a different category: peptides marketed online for unverified uses like reversing aging, treating diseases, or enhancing appearance. These products have become a staple within communities of wellness influencers and self-described biohackers, despite a notable absence of clinical evidence supporting the bold health claims.
During a late February appearance on a widely followed podcast, Kennedy amplified his position. He recounted personal use for injury treatment with “really good effect” and pledged to end what he termed the FDA’s “war on peptides.” His stated plan involves rolling back the agency’s regulatory actions against many of these substances.
This regulatory action followed a 2023 FDA decision to reclassify numerous peptides due to safety concerns. The move removed them from a list of drugs that specialized compounding pharmacies are permitted to formulate for individual patients, effectively banning their legal production for human use. This crackdown was a direct response to escalating and unsubstantiated marketing about their benefits. Despite the ban, a robust black and gray market for these products persists. They are often sold illicitly or under the guise of being for “research use only.” Notably, some individuals within Kennedy’s own circle of supporters and allies are involved in selling these unproven peptide treatments.
(Source: Ars Technica)
